Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age13-24
SponsorUniversity of California, Los Angeles

About this trial

This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.

Eligibility criteria

Qualifiers

age 13-24;

past-week suicidal behavior or ideation with plan or intent

Disqualifiers

symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information);

youth not fluent in English

parent not fluent in English or Spanish.

Trial design

Treatments tested in this trial

  • SAFETY-A within usual ED Care
  • Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts

Treatment groups

1,600 Participants
are divided into 2 treatment groups

Locations

5
Ronald Reagan Medical Center90095-6968, Los AngelesCalifornia, United States
Olive View UCLA Education and Research Center91342, SylmarCalifornia, United States
Duke University27708, DurhamNorth Carolina, United States
Brown University02912, ProvidenceRhode Island, United States

Sponsors and collaborators

University of California, Los Angeles

Lead sponsor

Duke University

Collaborator

Brown University

Collaborator

University of Utah

Collaborator

Olive View-UCLA Education & Research Institute

Collaborator

RAND

Collaborator

Patient-Centered Outcomes Research Institute

Collaborator